James Brandt, M.D.

James David Brandt, M.D.




  • Vice-Chair for International Programs & New Technology
  • Director of the Glaucoma Service
  • Professor of Ophthalmology & Vision Science


To see if James David Brandt is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Lawrence J. Ellison Ambulatory Care Center

4860 Y St., Suite 2400
Sacramento, CA 95817
Driving Directions

Primary Phone:

Additional Phone Numbers

Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Clinical Interests

Dr. Brandt’s clinical practice is limited to the diagnosis and management of all forms of glaucoma, with a particular focus on infantile and pediatric glaucoma.

He participates (and offers his patients the opportunity to be involved in) clinical trials of new medical and surgical approaches to the treatment of glaucoma.

Dr. Brandt is a frequent volunteer faculty member with ORBIS International, traveling worldwide to train glaucoma specialists in the management of pediatric glaucoma. 

Research/Academic Interests

Dr. Brandt has research interests in both the clinical and basic realms. In clinical research, he is a principal investigator in the landmark Ocular Hypertension Treatment Study and was largely responsible for one of the Study's most important findings to date, that thin corneal thickness is a risk factor for the development of glaucoma.

Dr. Brandt is actively involved in large clinical trials investigating new medical and surgical treatments of glaucoma and new technologies for diagnosing the disease. In the basic research arena, Dr. Brandt is currently collaborating with Dr. Tingrui Pan of the Department of Biomedical Engineering to develop new MEMS and Nanotechnology-based devices for the diagnosis of glaucoma.



Center/Program Affiliation

Eye Center


M.D., Harvard Medical School, Boston MA 1982

B.S., Yale University, New Haven CT 1978

Internship: General Surgery, University of Minnesota Hospitals, Minneapolis MN 1982-1983


Ophthalmology, University of Southern California, Los Angeles CA 1985-1988


Opthalmalmic Pharmacology & Cell Biology, Harvard Medical School - Eye Research Institute, Boston MA 1983-1985

Glaucoma, Wills Eye Hospital, Philadelphia PA 1988-1989

Board Certifications

American Board of Ophthalmology, 1989

Professional Memberships

American Academy of Ophthalmology

American Glaucoma Society

American Medical Association

Association for Research in Vision and Ophthalmology

California Association of Eye Physicians and Surgeon

California Medical Association

Glaucoma Research Society

World Glaucoma Association

Honors and Awards

Lifetime Achievement Award (American Academy of Ophthalmology, 2015

13th Annual Clinician-Scientist Lecturer (American Glaucoma Society, 2012

Listed in "Best Doctors in America" 1998-, 2016

Select Recent Publications

Nie B, Li R, Brandt JD & Pan T. Flexible transparent iontronic film for interfacial capacitive pressure sensing. Advanced Materials. 2015;27(39):6055-6062

Suhr AW, Lim MC, Brandt JD, Izquierdo JC & Willits N. Outcomes of Fornix-based versus Limbus-based Conjunctival Incisions for Glaucoma Drainage Device Implant. J of Glaucoma. 2012;21(8):523-529.

Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL; Tube versus Trabeculectomy Study Group. Treatment outcomes in the Tube Versus Trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012 May;153(5):789-803.

Brandt JD, Gordon MO, Gao F, Beiser JA, Miller JP & Kass MA. Ocular Hypertension Treatment Study Group Adjusting IOP for Central Corneal Thickness Does Not Improve Prediction Models for Primary Open-Angle Glaucoma. Ophthalmology. 2012;119(3):437-442.

Mochizuki H, Lesley AG & Brandt JD. Shrinkage of the scleral canal during cupping reversal in children. Ophthalmology. 2011;118(10):2008-2013.

Zangwill LM, Weinreb RN, Beiser J, Berry CC, Cioffi GA, Coleman AL, Trick G, Liebmann JM, Brandt JD, Piltz-Seymour JR, Dirkes KA, Vega S, Kass MA, Gordon MO. Ocular Hypertension Treatment CSLO Ancillary Study Group Predicting the Onset of Glaucoma: The Confocal Scanning Laser Ophthalmoscopy Ancillary Study to the Ocular Hypertension Treatment Study. Ophthalmology. 2010;117(9):1674-1683.

Brandt JD, Beiser JA, Gordon MO, Lin SC, Alexander MY, Kass MA. OHTS Study Group Changes in Central Corneal Thickness Over Time: The Ocular Hypertension Treatment Study. Ophthalmology. 2008;115(9):1550-1556.

Tanimoto SA & Brandt JD. Options in pediatric glaucoma after angle surgery has failed. Current Opinion in Ophthalmology. 2006;17:132-137.

Brandt, JD, Beiser JA, Gordon MO & Kass MA. Ocular Hypertension Treatment Study Group Central Corneal Thickness and IOP Response to Topical Ocular Hypotensive Medication in the Ocular Hypertension Treatment Study (OHTS). Am J of Ophthalmology. 2004;138(5):717-722.

Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK, Wilson MR, Kass MA. Ocular Hypertension Treatment Study Group The Ocular Hypertension Treatment Study: Baseline Factors that Predict the Development of Primary Open Angle Glaucoma. Archives of Ophthalmology. 2002;120(6):714-720.